UK Markets close in 5 hrs 31 mins

GSK Jan 2023 44.000 call

OPR - OPR Delayed price. Currency in USD
Add to watchlist
1.20000.0000 (0.00%)
As of 02:37PM EDT. Market open.
Full screen
Previous close1.2000
Open1.2000
Bid0.3500
Ask0.5000
Strike44.00
Expiry date2023-01-20
Day's range1.2000 - 1.2000
Contract rangeN/A
Volume3
Open interest2.62k
  • Reuters

    GSK picks Burberry's Brown as first female CFO

    (Reuters) -GSK named luxury fashion brand Burberry's Julie Brown as its first ever female chief financial officer on Monday to succeed Iain Mackay, at a time when the British drugmaker is sharpening focus on its core business. Mackay, 60, will be retiring next year after serving as GSK's finance chief for nearly four years. Brown, also 60, will join GSK in April and take up the job in May. She has previously done stints in the health and pharmaceuticals industry.

  • Sky News

    GSK poaches Burberry CFO to create all-female top team

    GSK, the FTSE-100 pharmaceuticals giant, has poached Burberry Group's finance chief to create a rare all-female executive leadership team in London's blue-chip share index. Sky News has learnt that GSK could announce as soon as Monday morning that it has recruited Julie Brown to replace Iain Mackay, who has served as its chief financial officer since 2019. The appointment of Ms Brown comes during a period of seismic change for GSK, which demerged its consumer healthcare business - now called Haleon - in a £30bn deal in July.

  • Zacks

    Spero (SPRO) Skyrockets 168% on Licensing Deal With GSK

    The exclusive licensing agreement with GSK will fund Spero's (SPRO) existing operations and extend its current cash runway beyond 2024.